Opportunities and challenges in leveraging electronic health record data in oncology

References

• 1 Howie L, Hirsch B, Locklear T, Abernethy AP. Assessing the value of patient-generated data to comparative effectiveness research. Health Aff. 33(7), 1220–1228 (2014).
  Google Scholar
• 2 Vassar M, Holzmann M. The retrospective chart review: important methodological considerations. J. Educ. Eval. Health Prof. 10(12), 1–7 (2013).
  MedlineGoogle Scholar
• 3 Manasanch EE, Smith JK, Bodnari A et al. Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors. J. Oncol. Pract. 7(2), 111–116 (2011).
  MedlineGoogle Scholar
• 4 Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J. Natl Cancer Inst. 94(20), 1537–1545 (2002).
  MedlineGoogle Scholar
• 5 Rosenbaum L. Perspective: transitional chaos or enduring harm? The HER and the disruption of medicine. N. Engl. J. Med. 373(17), 1585–1588 (2015).
  MedlineGoogle Scholar
• 6 Brookstone A. HIMSS13 – R satisfaction diminishing. www.americanehr.com/blog/2013/03/himss13-ehr-satisfaction-diminishing.
  Google Scholar
• 7 Koopman RJ, Steege LM, Moore JL et al. Physician information needs and electronic records (EHRs): time to reengineer the clinic note. J. Am. Board Fam. Med. 28(3), 316–323 (2015).
  MedlineGoogle Scholar
• 8 Fernandopulle R, Patel N. How the electronic health record did not measure up to the demands of our medical home practice. Health Aff. 29(4), 622–628 (2010).
  Google Scholar
• 9 LeBlanc TW, Back AL, Danis M, Abernethy AP. Electronic health records (EHRs) in the oncology clinic: how clinician interaction with EHRs can improve communication with the patient. J. Oncol. Pract. 10(5), 317–321 (2014).
  MedlineGoogle Scholar
• 10 Infrastructure for the Learning Health System: The Foundation for Continuous Improvement in Health and Health Care: Workshop Series Summary. Grossman C, Powers B, McGinnis JM (Eds). National Academies Press, Washington, DC, USA (2011).
  Google Scholar
• 11 Vest JR, Gamm LD. Health information exchange: persistent challenges and new strategies. J. Am. Med. Inform. Assoc. 17, 288–294 (2010).
  MedlineGoogle Scholar
• 12 American Society of Clinical Oncology. Cancer-specific data sharing standards for communication, collaboration, and coordination of care. www.asco.org/practice-research/cancer-specific-data-sharing-standards-communication-collaboration-and.
  Google Scholar
• 13 Kite BJ, Tangasi W, Kelley M, Bower JK, Foraker RE. Electronic medical records and their use in health promotion and population research of cardiovascular disease. Curr. Cardiovasc. Risk Rep. 9, 422–425 (2015).
  Google Scholar
• 14 Kohane IS. Using electronic health records to drive discovery in disease genomics. Nat. Rev. Genet. 12, 417–428 (2011).
  Medline CASGoogle Scholar
• 15 Walker AM, Zhou X, Ananthakrishnan AN et al. Computer-assisted expert case definition in electronic health records. Int. J. Med. Inform. 86, 62–70 (2016).
  MedlineGoogle Scholar
• 16 Carrell DS, Cronkite D, Palmer RE et al. Using natural language processing to identify problem usage of prescription opioids. Int. J. Med. Inform. 84(12), 1057–1064 (2015).
  MedlineGoogle Scholar
• 17 Vijayakrishnan R, Steinhubl SR, Ng K et al. Prevalence of heart failure signs and symptoms in a large primary care population identified through the use of text and data mining of the electronic health record. J. Card. Fail. 20(7), 459–464 (2014).
  MedlineGoogle Scholar
• 18 Byrd RJ, Steinhubl SR, Sun J, Ebadollahi S, Stewart WF. Automatic identification of heart failure diagnostic criteria, using text analysis of clinical notes from electronic health records. Int. J. Med. Inform. 83(12), 983–992 (2014).
  MedlineGoogle Scholar
• 19 Zheng C, Rashid N, Koblick R, An J. Medication extraction from electronic clinical notes in an integrated health system: a study on aspirin use in patients with nonvalvular atrial fibrillation. Clin. Ther. 37(9), 2048–2058 (2015).
  MedlineGoogle Scholar
• 20 Raghavan P, Chen JL, Fosler-Lussier, Lai AM. How essential are unstructured clinical narratives and information fusion to clinical trial recruitment? AMIA Jt Summits Transl. Sci. Proc. 218–223 (2014).
  MedlineGoogle Scholar
• 21 Da Graca B, Filardo G, Nicewander D. Consequences for healthcare quality and research of the exclusion of records from the Death Master File. Circ. Cardiovasc. Qual. Outcomes. 6(1), 124–128 (2013).
  MedlineGoogle Scholar
• 22 Blackstone EH. Demise of a vital resource. J. Thorac. Cardiovasc. Surg. 143(1), 37–38 (2012).
  MedlineGoogle Scholar
• 23 Liede A, Hernandez RK, Roth M, Calkins G, Larrabee K, Nicacio L. Validation of international classification of diseases coding for bone metastases in electronic health records using technology-enabled abstraction. Clin. Epidemiol. 7, 441–448 (2015).
  MedlineGoogle Scholar
• 24 Ho C, Ramsden K, Zhai Y et al. Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10 year retrospective population-based review. J. Thorac. Oncol. 9(8), 1180–1186 (2014).
  Medline CASGoogle Scholar
• 25 Schink J, Trosman J, Weldon C et al. biomarker testing for breast, lung, and esophageal cancers at NCI designated cancer centers. J. Natl Cancer Inst. doi:10.1093/jnci/dju256 (2014) (Epub ahead of print).
  MedlineGoogle Scholar
• 26 Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J. Biomed. Inform. 46, 830–836 (2013).
  MedlineGoogle Scholar
• 27 Warner JL, Levy MA, Neuss MN. Feasibility and accuracy of extracting cancer stage information from narrative electronic health record data. J. Oncol. Pract. doi:10.1200/JOP.2015.004622 (2015) (Epub ahead of print).
  Google Scholar
• 28 Carrell DS, Halgrim S, Tran DT et al. Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. Am. J. Epidemiol. 179(6), 749–758 (2014).
  MedlineGoogle Scholar
• 29 Robinson R. 21st Century Cures Act. Pharmavoice Nov/Dec 2015. www.pharmavoice.com/article/2015–2011-cures-act.
  Google Scholar
• 30 Abernethy AP, Etheredge LM, Ganz PA et al. Rapid-learning system for cancer care. J. Clin. Oncol. 28(27), 4268–4274 (2010).
  MedlineGoogle Scholar
• 31 Newcomer LN, Gould B, Page RD, Donelan SA, Perkins M. Changing physician incentives for affordable, quality cancer care: results of an episode payment model. J. Oncol. Pract. 10(5), 322–326 (2014).
  MedlineGoogle Scholar
• 32 CMS.gov. Center for Medicare and Medicaid Services. Oncology care model. http://innovation.cms.gov/initiatives/Oncology-Care.
  Google Scholar
• 33 Kelly C. NCCN Drug affordability ratings will start with multiple myeloma, leukemia. The Pink Sheet 7 September 2015. https://www.pharmamedtechbi.com/publications/the-pink-sheet/77/36/nccn-drug-affordability-ratings-will-start-with-multiple-myeloma-leukemia.
  Google Scholar
• 34 Loftus P. New Push Ties Cost of Drugs to How Well They Work. The Wall Street Journal 26 May 2015. www.wsj.com/articles/new-push-ties-cost-of-drugs-to-how-well-they-work-1432684755.
  Google Scholar
• 35 Neumann PJ, Chambers JD, Simon F, Meckley LM. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement. Health Aff. 30(12), 2329–2337 (2011).
  Google Scholar
• 36 Jarosławski S, Toumi M. Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying Concepts. BMC Health Services Res. 11, 259 (2011).
  MedlineGoogle Scholar
• 37 Adamski J, Godman B, Ofierska-Sujkowska G. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Services Res. 10, 153 (2010).
  MedlineGoogle Scholar